Maternal Preeclampsia Predicts the Development of Bronchopulmonary Dysplasia

被引:176
作者
Hansen, Anne R. [1 ]
Barnes, Carmen M. [2 ]
Folkman, Judah [2 ]
McElrath, Thomas F. [3 ]
机构
[1] Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA
[2] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; BIRTH-WEIGHT INFANTS; INHALED NITRIC-OXIDE; RISK-FACTORS; LUNG INJURY; CHRONIC HYPERTENSION; FACTOR CONTRIBUTES; PRETERM DELIVERY; SOLUBLE ENDOGLIN; FACTOR RECEPTOR;
D O I
10.1016/j.jpeds.2009.10.018
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To test the hypothesis that exposure to preeclampsia is associated with an increased risk of bronchopulmonary dysplasia (BPD). Study design A prospective cohort study of 107 babies born between 23 and 32 weeks gestation, collecting maternal, neonatal, and placental data. Results Of the 107 infants studied, 27 (25%) developed BPD. The bivariate odds ratio (OR) for the relationship between pre-eclampsia and BPD was 2.96 (95% confidence interval [CI] = 1.17 to 7.51; P = .01). When controlling for gestational age, birth weight z-score, chorioamnionitis, and other clinical confounders, the OR of developing BPD was 18.7 (95% CI = 2.44 to 144.76). Including the occurrence of preeclampsia, clinical chorioamnionitis, male sex, and maternal tobacco use in addition to gestational age and birth weight z-score accounted for 54% of the variability of the odds of developing BPD. Conclusions BPD is increased for infants exposed to preeclampsia. This has possible implications for the prevention of BPD with proangiogenic agents, such as vascular endothelial growth factor. (J Pediatr 2010; 156: 532-6).
引用
收藏
页码:532 / 536
页数:5
相关论文
共 44 条
[1]   Bronchopulmonary dysplasia: A genetic disease [J].
Abman, Steven H. ;
Mourani, Peter M. ;
Sontag, Marci .
PEDIATRICS, 2008, 122 (03) :658-659
[2]  
*AM COLL OBST GYN, 2002, OBSTET GYNECOL JAN, P159
[3]   Neonatal outcome in pregnancies after preterm delivery for HELLP syndrome [J].
Aslan, H ;
Gul, A ;
Cebeci, A .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2004, 58 (02) :96-99
[4]   Inhaled nitric oxide for preterm infants: A systematic review [J].
Barrington, Keith J. ;
Finer, Neil N. .
PEDIATRICS, 2007, 120 (05) :1088-1099
[5]   Maternal hypertensive disorders are an independent risk factor for the development of necrotizing enterocolitis in very low birth weight infants [J].
Bashiri, A ;
Zmora, E ;
Sheiner, E ;
Hershkovitz, R ;
Shoham-Vardi, A ;
Mazor, M .
FETAL DIAGNOSIS AND THERAPY, 2003, 18 (06) :404-407
[6]   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583
[7]   Increased expression of placenta growth factor in COPD [J].
Cheng, S-L ;
Wang, H-C ;
Yu, C-J ;
Yang, P-C .
THORAX, 2008, 63 (06) :500-506
[8]   IMPROPER USE OF STATISTICAL SIGNIFICANCE TESTING IN STUDYING COVARIABLES [J].
DALES, LG ;
URY, HK .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1978, 7 (04) :373-375
[9]  
DUFF P, 2009, MATERNAL FETAL MED P, P757
[10]  
FRIEDMAN SA, 1996, AM J OBSTET GYNECOL, V174, P1788